Over the past five years, diabetes-focused medical device specialist DexCom (NASDAQ: DXCM) has made meaningful progress on several fronts. The company launched new products in the continuous glucose ...

DexCom's growth rate has been accelerating for multiple quarters, and recently came in at around 22%. A rise in GLP-1 drugs has some investors concerned that DexCom's growth opportunities may be ...

DexCom overview and recent share performance DexCom (DXCM) has drawn fresh attention as investors reassess its continuous glucose monitoring business and recent share performance, with the stock last ...

Wondering if DexCom stock is a hidden bargain or just riding a wave? You are not alone, and today's market swings only add to the intrigue. DexCom shares have jumped 5.4% over the past week even after ...

DexCom, Inc.'s growth is impressive but limited by its niche market, with my projected ceiling being ~$7.5bn in peak annual revenues. Despite positive Q4 2024 results, DexCom's stock is fairly valued, ...

Currently, DexCom has a market capitalization of $51.74 billion. Buying $1000 In DXCM: If an investor had bought $1000 of DXCM stock 5 years ago, it would be worth $4,603.38 today based on a price of ...

EDINBURGH - DexCom , Inc. (NASDAQ:DXCM), a pioneer in real-time continuous glucose monitoring (CGM) technology, has announced the integration of its Dexcom (NASDAQ: DXCM) G6 CGM system with the ...